1691 related articles for article (PubMed ID: 33688928)
1. Association of Antihypertensive Drug Target Genes With Psychiatric Disorders: A Mendelian Randomization Study.
Chauquet S; Zhu Z; O'Donovan MC; Walters JTR; Wray NR; Shah S
JAMA Psychiatry; 2021 Jun; 78(6):623-631. PubMed ID: 33688928
[TBL] [Abstract][Full Text] [Related]
2. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
[TBL] [Abstract][Full Text] [Related]
3. Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations.
Fan B; Zhao JV
BMC Med; 2024 Jan; 22(1):6. PubMed ID: 38166843
[TBL] [Abstract][Full Text] [Related]
4. Alcohol drinking, DNA methylation and psychiatric disorders: A multi-omics Mendelian randomization study to investigate causal pathways.
Shi X; Li M; Yao J; Li MD; Yang Z
Addiction; 2024 Jul; 119(7):1226-1237. PubMed ID: 38523595
[TBL] [Abstract][Full Text] [Related]
5. Genetically predicted blood pressure, antihypertensive drugs and risk of heart failure: a Mendelian randomization study.
Lian J; Shi X; Jia X; Fan J; Wang Y; Zhao Y; Yang Y
J Hypertens; 2023 Jan; 41(1):44-50. PubMed ID: 36129112
[TBL] [Abstract][Full Text] [Related]
6. Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders.
Li X; Shen A; Zhao Y; Xia J
Schizophr Bull; 2023 Sep; 49(5):1305-1315. PubMed ID: 37418754
[TBL] [Abstract][Full Text] [Related]
7. Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.
Baird DA; Liu JZ; Zheng J; Sieberts SK; Perumal T; Elsworth B; Richardson TG; Chen CY; Carrasquillo MM; Allen M; Reddy JS; De Jager PL; Ertekin-Taner N; Mangravite LM; Logsdon B; Estrada K; Haycock PC; Hemani G; Runz H; Smith GD; Gaunt TR;
PLoS Genet; 2021 Jan; 17(1):e1009224. PubMed ID: 33417599
[TBL] [Abstract][Full Text] [Related]
8. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
Cross-Disorder Group of the Psychiatric Genomics Consortium
Lancet; 2013 Apr; 381(9875):1371-1379. PubMed ID: 23453885
[TBL] [Abstract][Full Text] [Related]
9. Novel loci and potential mechanisms of major depressive disorder, bipolar disorder, and schizophrenia.
Wang H; Yi Z; Shi T
Sci China Life Sci; 2022 Jan; 65(1):167-183. PubMed ID: 34159505
[TBL] [Abstract][Full Text] [Related]
10. Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits.
Legge SE; Jones HJ; Kendall KM; Pardiñas AF; Menzies G; Bracher-Smith M; Escott-Price V; Rees E; Davis KAS; Hotopf M; Savage JE; Posthuma D; Holmans P; Kirov G; Owen MJ; O'Donovan MC; Zammit S; Walters JTR
JAMA Psychiatry; 2019 Dec; 76(12):1256-1265. PubMed ID: 31553412
[TBL] [Abstract][Full Text] [Related]
11. Body mass index and psychiatric disorders: a Mendelian randomization study.
Hartwig FP; Bowden J; Loret de Mola C; Tovo-Rodrigues L; Davey Smith G; Horta BL
Sci Rep; 2016 Sep; 6():32730. PubMed ID: 27601421
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drug target gene associations with major depressive disorders: a Mendelian randomisation study integrating GWAS, eQTL and mQTL Data.
He Q; Wu KCH; Bennett AN; Fan B; Liu J; Huang R; Kong APS; Tian X; Kwok MKM; Chan KHK
Pharmacogenomics J; 2023 Jul; 23(4):95-104. PubMed ID: 36966195
[TBL] [Abstract][Full Text] [Related]
13. ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study.
Pigeyre M; Sjaarda J; Chong M; Hess S; Bosch J; Yusuf S; Gerstein H; Paré G
Diabetes Care; 2020 Apr; 43(4):835-842. PubMed ID: 32019855
[TBL] [Abstract][Full Text] [Related]
14. Expression of ZNF804A in human brain and alterations in schizophrenia, bipolar disorder, and major depressive disorder: a novel transcript fetally regulated by the psychosis risk variant rs1344706.
Tao R; Cousijn H; Jaffe AE; Burnet PW; Edwards F; Eastwood SL; Shin JH; Lane TA; Walker MA; Maher BJ; Weinberger DR; Harrison PJ; Hyde TM; Kleinman JE
JAMA Psychiatry; 2014 Oct; 71(10):1112-20. PubMed ID: 25162540
[TBL] [Abstract][Full Text] [Related]
15. Assessing the Causal Effects of Human Serum Metabolites on 5 Major Psychiatric Disorders.
Yang J; Yan B; Zhao B; Fan Y; He X; Yang L; Ma Q; Zheng J; Wang W; Bai L; Zhu F; Ma X
Schizophr Bull; 2020 Jul; 46(4):804-813. PubMed ID: 31919502
[TBL] [Abstract][Full Text] [Related]
16. Genetically Proxied Diurnal Preference, Sleep Timing, and Risk of Major Depressive Disorder.
Daghlas I; Lane JM; Saxena R; Vetter C
JAMA Psychiatry; 2021 Aug; 78(8):903-910. PubMed ID: 34037671
[TBL] [Abstract][Full Text] [Related]
17. Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization.
Woolf B; Cronjé HT; Zagkos L; Burgess S; Gill D; Larsson SC
BMC Med; 2023 Aug; 21(1):296. PubMed ID: 37553644
[TBL] [Abstract][Full Text] [Related]
18. Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study.
Prins BP; Abbasi A; Wong A; Vaez A; Nolte I; Franceschini N; Stuart PE; Guterriez Achury J; Mistry V; Bradfield JP; Valdes AM; Bras J; Shatunov A; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Lu C; Han B; Raychaudhuri S; Bevan S; Mayes MD; Tsoi LC; Evangelou E; Nair RP; Grant SF; Polychronakos C; Radstake TR; van Heel DA; Dunstan ML; Wood NW; Al-Chalabi A; Dehghan A; Hakonarson H; Markus HS; Elder JT; Knight J; Arking DE; Spector TD; Koeleman BP; van Duijn CM; Martin J; Morris AP; Weersma RK; Wijmenga C; Munroe PB; Perry JR; Pouget JG; Jamshidi Y; Snieder H; Alizadeh BZ
PLoS Med; 2016 Jun; 13(6):e1001976. PubMed ID: 27327646
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study.
Hartwig FP; Borges MC; Horta BL; Bowden J; Davey Smith G
JAMA Psychiatry; 2017 Dec; 74(12):1226-1233. PubMed ID: 29094161
[TBL] [Abstract][Full Text] [Related]
20. GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores.
Mullins N; Bigdeli TB; Børglum AD; Coleman JRI; Demontis D; Mehta D; Power RA; Ripke S; Stahl EA; Starnawska A; Anjorin A; ; Corvin A; Sanders AR; Forstner AJ; Reif A; Koller AC; Świątkowska B; Baune BT; Müller-Myhsok B; Penninx BWJH; Pato C; Zai C; Rujescu D; Hougaard DM; Quested D; Levinson DF; Binder EB; Byrne EM; Agerbo E; ; Streit F; Mayoral F; Bellivier F; Degenhardt F; Breen G; Morken G; Turecki G; Rouleau GA; Grabe HJ; Völzke H; Jones I; Giegling I; Agartz I; Melle I; Lawrence J; ; Walters JTR; Strohmaier J; Shi J; Hauser J; Biernacka JM; Vincent JB; Kelsoe J; Strauss JS; Lissowska J; Pimm J; ; Smoller JW; Guzman-Parra J; Berger K; Scott LJ; Jones LA; Azevedo MH; Trzaskowski M; Kogevinas M; Rietschel M; Boks M; Ising M; Grigoroiu-Serbanescu M; Hamshere ML; Leboyer M; Frye M; Nöthen MM; Alda M; Preisig M; Nordentoft M; Boehnke M; O'Donovan MC; Owen MJ; Pato MT; Renteria ME; Budde M; ; Weissman MM; Wray NR; Bass N; ; Craddock N; Smeland OB; Andreassen OA; Mors O; Gejman PV; Sklar P; McGrath P; Hoffmann P; McGuffin P; Lee PH; Mortensen PB; Kahn RS; Ophoff RA; Adolfsson R; Van der Auwera S; Djurovic S; Kloiber S; Heilmann-Heimbach S; Jamain S; Hamilton SP; McElroy SL; Lucae S; Cichon S; Schulze TG; Hansen T; Werge T; Air TM; Nimgaonkar V; Appadurai V; Cahn W; Milaneschi Y; ; ; ; Fanous AH; Kendler KS; McQuillin A; Lewis CM
Am J Psychiatry; 2019 Aug; 176(8):651-660. PubMed ID: 31164008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
